SIS: Recovery on the way; Attractive valuations; reiterate Buy (SECIS IN, Mkt Cap USD1b, CMP INR482, TP INR600, 25% Upside, Buy) SIS reported a lower than expected performance in 1QFY22, led by underperformance in the international business (-4.2% QoQ) on account of lower revenue from the ad hoc business (also high margin) and two months impact of the lockdown on the India Security business (-2.3% QoQ). This led to a sequential decline of 2.7%. Consequently, EBITDA margin was lower than o...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.